Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02171104Phase 2Active Not Recruiting
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Acyl-CoA Oxidase DeficiencyAdrenoleukodystrophy With Cerebral InvolvementAlpha-Mannosidosis+26 more
PrincipalinvestigatorStart date: 2014-07-10
NCT01572636Terminated
Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
Hurler SyndromeMPS IMucopolysaccharidosis Type IH
PrincipalinvestigatorStart date: 2012-03-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Orchard, MD

Masonic Cancer Center, University of Minnesota

Related
9 trials

Shared therapeutic areas:

Leukodystrophy, Globoid CellHurler SyndromeFucosidosis+9 more

Worked with same sponsors:

Masonic Cancer Center, University of Minnesota
Similarity Score12%

Paul Orchard, MD

University of Minnesota Medical Center

Related
3 trials

Shared therapeutic areas:

Hurler Syndromealpha-MannosidosisAspartylglucosaminuria+5 more

Worked with same sponsors:

Masonic Cancer Center, University of Minnesota
Similarity Score8%

K. Scott Baker

Fairview University Medical Center

Related
3 trials

Shared therapeutic areas:

FucosidosisLeukodystrophy, Globoid CellLeukodystrophy, Metachromatic+1 more
Similarity Score4%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

FucosidosisLeukodystrophy, Globoid CellLeukodystrophy, Metachromatic+1 more
Similarity Score4%

Melissa Wasserstein, MD

Albert Einstein College of Medicine

Related
2 trials

Shared therapeutic areas:

Leukodystrophy, MetachromaticMucopolysaccharidosis IIMucopolysaccharidosis VI+1 more
Similarity Score4%

Kenneth Setchell, PhD

Children's Hospital Medical Center, Cincinnati

Related
3 trials

Shared therapeutic areas:

Refsum Disease, InfantilePeroxisomal DisordersZellweger Syndrome
Similarity Score3%

Chester B. Whitley, M.D., Ph.D.

University of Minnesota

Related
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IIMucopolysaccharidosis VIMucopolysaccharidosis VII
Similarity Score3%

Ashley Schneider

University of Minnesota

Related
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IIMucopolysaccharidosis VIMucopolysaccharidosis VII
Similarity Score3%

Peter Bauer, Prof.

Centogene GmbH

Related
25 trials

Shared therapeutic areas:

alpha-MannosidosisHurler SyndromeLeukodystrophy, Globoid Cell
Similarity Score3%

Suzanne T Ildstad, MD

Talaris Therapeutics Inc.

Related
6 trials

Shared therapeutic areas:

alpha-MannosidosisLeukodystrophy, Metachromatic
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02171104Phase 2PrincipalInvestigator

MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

Acyl-CoA Oxidase DeficiencyAdrenoleukodystrophy With Cerebral InvolvementAlpha-Mannosidosis+26 more
Active Not Recruiting
NCT01572636PrincipalInvestigator

Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome

Hurler SyndromeMPS IMucopolysaccharidosis Type IH
Terminated

All 2 trials loaded